- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00342277
Microarray Expression Profiling to Identify Stereotypic mRNA Profiles in Human Parturition
February 22, 2023 updated by: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The understanding of the biological mechanisms underlying preterm birth is very limited, making prevention of preterm birth difficult.
The incidence of preterm birth worldwide varies between 6%-11% in singleton pregnancies, and 64-93% of preterm deliveries occur after the spontaneous onset of labor (preterm labor).
The risk factors associated with preterm birth include demographic variables such as ethnic group, past obstetric history, and complications of the current pregnancy such as infection and fetal congenital anomalies.
The current study aims to investigate the basic mechanisms of preterm labor by systematically cataloging the changes in expression levels of all expressed genes whose sequences are available.
The goals will be accomplished by using microarray technology followed by subsequent confirmative or complementary analyses.
Study Overview
Status
Completed
Conditions
Detailed Description
The understanding of the biological mechanisms underlying preterm birth is very limited, making prevention of preterm birth difficult.
The incidence of preterm birth worldwide varies between 6%-11% in singleton pregnancies, and 64-93% of preterm deliveries occur after the spontaneous onset of labor (preterm labor).
The risk factors associated with preterm birth include demographic variables such as ethnic group, past obstetric history, and complications of the current pregnancy such as infection and fetal congenital anomalies.
The current study aims to investigate the basic mechanisms of preterm labor by systematically cataloging the changes in expression levels of all expressed genes whose sequences are available.
The goals will be accomplished by using microarray technology followed by subsequent confirmative or complementary analyses.
Study Type
Observational
Enrollment (Actual)
6838
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Puente Alto, Chile
- Sotero del Rio Hospital
-
-
-
-
-
Padova, Italy
- Padova Hospital
-
-
-
-
-
Seoul, Korea, Republic of
- Seoul National University
-
-
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Wayne State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Pregnant women aged 15 years and older at 18 - 36 weeks of gestation admitted with the following diagnoses:@@@1) preterm labor with intact membranes@@@2) preterm delivery without labor@@@3) PROM leading to preterm delivery@@@4) Term deliveries without labor/spontaneous labor/with chorioamnionitis/with failed labor leading to cesarean section
Description
- INCLUSION CRITERIA:
Consecutive patients admitted with the following diagnoses from four different ethnic groups (Hispanic, African American, Asian, and Caucasian):
Preterm labor with intact membranes and with
- acute inflammation;
- chronic villitis;
- vascular pathology;
- no identifiable lesions.
Preterm delivery without labor because of the following reasons:
- pre-eclampsia;
- abruptio placentae;
- fetal anomalies;
- Other complications (e.g. automobile accidents) that necessitate immediate delivery.
PROM leading to preterm delivery and with
- acute inflammation;
- chronic villitis;
- vascular pathology;
- no identifiable lesions.
- Term delivery without labor and no identifiable lesions.
- Term delivery in spontaneous labor and no identifiable lesions.
- Term delivery with chorioamnionitis.
- Term delivery with failed labor leading to ceasarean section.
EXCLUSION CRITERIA:
- Refusal of written informed consent
- Fetal or maternal conditions mandating immediate delivery (i.e. fetal distress, significant hemorrhage, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Pregnant Women
Consecutive pregnant women admitted with either: Preterm labor/delivery/PROM.
Termdelivery without labor/spontaneous labor /chorioamnionitis/failed labor leading to c-section
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To identify genes that are up- or down-regulated in preterm delivery and preterm PROM using microarray expression profiling.
Time Frame: After the study is closed to accrual
|
Investigate the basic mechanisms of preterm labor by systematically cataloging the changes in expression levels of all expressed genes whose sequences are available.
|
After the study is closed to accrual
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 21, 1999
Primary Completion (Actual)
May 5, 2016
Study Completion (Actual)
May 5, 2016
Study Registration Dates
First Submitted
June 19, 2006
First Submitted That Met QC Criteria
June 19, 2006
First Posted (Estimate)
June 21, 2006
Study Record Updates
Last Update Posted (Actual)
February 24, 2023
Last Update Submitted That Met QC Criteria
February 22, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 999999056
- OH99-CH-N056
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Birth
-
e-Bio CorpRecruitingPreterm Labor | PreTerm Birth | Preterm Labor With Delivery NosUnited States
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
Cairo UniversityCompleted
-
University of OklahomaCompletedPreTerm Birth | PreTerm NeonateUnited States
-
Thomas Jefferson UniversityCompleted
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
Federico II UniversityRecruiting
-
University of OxfordShoklo Malaria Research UnitCompleted
-
Eunice Kennedy Shriver National Institute of Child...CompletedPregnancy | Preterm Birth | Preterm LaborUnited States
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland